SPACE PEPTIDES PHARMACEUTICAL

PEPTIDE DRUG DISCOVERY (CRO) AND MANUFACTURE (CDMO)

Space Peptides appoints Dr. Hongming Chen as Technology Advisor

Space Peptides Pharmaceutical is pleased to welcome Dr. Hongming Chen as Technology Advisor.

After working as postdoctoral fellow in computational chemistry in Bayer Pharma Research Center in Wuppertal, Germany, Dr. Hongming Chen joined AstraZeneca R&D Mölndal, Sweden, in 2001. He has been focusing on QSAR modeling and chemoinformatics, and has delivered various predictive tools and computational chemistry support to the AstraZeneca Compound Collection Enhancement and Predictive Chemistry initiatives, as well as to numerous early drug discovery projects. He has authored/coauthored 30 scientific papers and three book chapters.

Hongming Chen studied polymer material engineering in Northwestern Polytechnical University, China, and obtained his PhD in computational chemistry in 1998 from the Institute of Chemical Metallurgy, Chinese Academy of Sciences.